Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intraoperative Quantification of Residual IDH1-mutant Tumor Cells Via Ultra-Rapid Droplet Digital PCR

NCT07219199 is registered in ClinicalTrials.gov with NYU Langone Health as lead sponsor.

NCT NCT07219199
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07219199 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intraoperative Quantification of Residual IDH1-mutant Tumor Cells Via Ultra-Rapid Droplet Digital PCR
Lead sponsor
NYU Langone Health
Phase
Not applicable
Overall status
Not yet recruiting
Start date
August 31, 2027
Completion date
August 31, 2032
Enrollment
105 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

glioma